This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Jennifer Franklin
Executive Director, CMC Regulatory Affairs at Ionis Pharmaceuticals
Speaker

Profile

Jenny has worked for Ionis Pharmaceuticals, Inc. for 18 years. For the past eight, she has been responsible for CMC Regulatory Affairs for Ionis programs from early development through marketing authorization and commercial lifecycle management. Prior to that, she was responsible for Quality Assurance oversight of oligonucleotide drug substance manufacturing and testing activities, and associated functions. Before joining Ionis, Jenny worked in Quality Control for Gala Biotech (now Catalent BioPharma). She earned her B.S in Biology and French from the University of Wisconsin.

Agenda Sessions

  • Practical Application of Platform Approaches for Oligonucleotides

    10:45